These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1492 related articles for article (PubMed ID: 23720280)

  • 21. Impaired muscle AMPK activation in the metabolic syndrome may attenuate improved insulin action after exercise training.
    Layne AS; Nasrallah S; South MA; Howell ME; McCurry MP; Ramsey MW; Stone MH; Stuart CA
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1815-26. PubMed ID: 21508135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble insulin receptor and metabolic syndrome.
    Hiriart-Urdanivia M; Sánchez-Soto C; Velasco M; Sabido-Barrera J; Ortiz-Huidobro RI
    Gac Med Mex; 2019; 155(5):500-503. PubMed ID: 32091018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus.
    Simonson GD; Kendall DM
    Coron Artery Dis; 2005 Dec; 16(8):465-72. PubMed ID: 16319655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.
    Rask-Madsen C; Kahn CR
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2052-9. PubMed ID: 22895666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Resistance Exercise on Serum Osteoprotegerin Levels and Insulin Resistance in Middle-Aged Women with Metabolic Syndrome.
    Hur S; Cho SH; Song BK; Cho BJ
    Med Sci Monit; 2018 Dec; 24():9385-9391. PubMed ID: 30582576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.
    Song R; Peng W; Zhang Y; Lv F; Wu HK; Guo J; Cao Y; Pi Y; Zhang X; Jin L; Zhang M; Jiang P; Liu F; Meng S; Zhang X; Jiang P; Cao CM; Xiao RP
    Nature; 2013 Feb; 494(7437):375-9. PubMed ID: 23354051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.
    Wittwer J; Bradley D
    Front Immunol; 2021; 12():612496. PubMed ID: 33717095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes.
    Fealy CE; Nieuwoudt S; Foucher JA; Scelsi AR; Malin SK; Pagadala M; Cruz LA; Li M; Rocco M; Burguera B; Kirwan JP
    Exp Physiol; 2018 Jul; 103(7):985-994. PubMed ID: 29766601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?
    Kränkel N; Bahls M; Van Craenenbroeck EM; Adams V; Serratosa L; Solberg EE; Hansen D; Dörr M; Kemps H
    Eur J Prev Cardiol; 2019 May; 26(7):701-708. PubMed ID: 30317879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
    Robinson LE; Graham TE
    Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.
    Carroll S; Dudfield M
    Sports Med; 2004; 34(6):371-418. PubMed ID: 15157122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance as the underlying cause for the metabolic syndrome.
    Lann D; LeRoith D
    Med Clin North Am; 2007 Nov; 91(6):1063-77, viii. PubMed ID: 17964909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia and exercise interactions on skeletal muscle insulin sensitivity in obese subjects with metabolic syndrome: results of a randomized controlled trial.
    Mai K; Klug L; Rakova N; Piper SK; Mähler A; Bobbert T; Schulz-Menger J; Spranger J; Boschmann M; Luft FC
    Int J Obes (Lond); 2020 May; 44(5):1119-1128. PubMed ID: 31819201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The link between the metabolic syndrome and cancer.
    Braun S; Bitton-Worms K; LeRoith D
    Int J Biol Sci; 2011; 7(7):1003-15. PubMed ID: 21912508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of body mass index and insulin resistance with metabolic syndrome in Brazilian children.
    Ferreira AP; Nóbrega Ode T; França NM
    Arq Bras Cardiol; 2009 Aug; 93(2):147-53. PubMed ID: 19838492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing management of metabolic syndrome to reduce risk: focus on life-style.
    Bianchi C; Penno G; Daniele G; Benzi L; Del Prato S; Miccoli R
    Intern Emerg Med; 2008 Jun; 3(2):87-98. PubMed ID: 18270793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome.
    Wewege MA; Thom JM; Rye KA; Parmenter BJ
    Atherosclerosis; 2018 Jul; 274():162-171. PubMed ID: 29783064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.